Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fischer and R2 join forces:

This article was originally published in Clinica

Executive Summary

Fischer Imaging is to integrate R2 Technology's computer aided detection (CAD) software into its SenoScan full field digital mammography (FFDM) system, following an agreement between the two firms. Under the deal, Fischer will have sole worldwide distribution rights to its FFDM system integrated with R2's technology, called ImageChecker. The combination of the two devices will require US approval for clinical use and both companies are each preparing the FDA premarket approval supplements to obtain clearance. The CAD technology is designed to detect findings that physicians might otherwise miss when reviewing mammograms, says Fischer, of Denver, Colorado.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel